MALVERN, Pa., October 26, 2023 — LifeSensors, Inc., a leading innovator in protein degradation technologies, has been invited to speak at the 6th Annual Targeted Protein Degradation Summit 2023 in…
Read More
[Malvern, PA, October 18, 2023] — LifeSensors Inc., a biotech company targeting the ubiquitin proteasome system for drug discovery and diagnostic markers, has received funding from the National Institute on...
Read More
MALVERN, Pa., SEP 21, 2023 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, molecular glue drug discovery and neurodegeneration diagnostics has been invited to speak at the…
MALVERN, PA., May 30, 2023 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTACs, molecular glues, and neurodegeneration diagnostics will disclose direct methods to detect PROTAC & molecular glue…
LifeSensors is Attending ASCB | EMBO Cell Bio 2022 MALVERN, PA., AUG 30, 2022 -- LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTACs, molecular glues, and neurodegeneration...
Read More
LifeSensors Invited to Speak at the Industry’s Preeminent 20th Annual Discovery on Target Conference
LifeSensors Invited to Speak at the Industry’s Preeminent 20th Annual Discovery on Target Conference MALVERN, Pa., AUG 30, 2022 -- LifeSensors Inc., a Biotech and Drug Discovery Company focused on...
Read More
LifeSensors Attending the 5th Annual Targeted Protein Degradation Summit MALVERN, PA., AUG 30, 2022 -- LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, Molecular Glues, and neurodegeneration...
Read More
DTE proteins, or ‘difficult-to-express’ proteins are a common hurdle for researchers in the lab. Due to difficulty with correct protein folding and general protein synthesis success, coronavirus proteins find themselves…
LifeSensors is happy to say we’re growing! We’ve always been one to say more the merrier, and now we truly are. With Axxora, we can offer near-complete global availability to...
Read More
FDA Provisional Approval LifeSensors is proud to announce its provisional FDA approval for our COVID-19 IgG ELISA Detection Kit to address the critical need for COVID-19 diagnostics through serological testing….
IgG & Total Antibody Kit At LifeSensors, we value and believe that a reliable and affordable test against COVID-19 can protect patients and healthcare professionals from around the world by…
LifeSensors, Inc is pleased to announce it has been granted CLIA certification in light of the COVID-19 pandemic. With this new certification, LifeSensors will be able to aid with the…
LifeSensors is a proud sponsor of the EMBO Ubiquitin Workshop in Cavtat, Croatia from September 13-17, 2019! This workshop is important to the Ubiquitin community to inspire further progress and collaboration.
Read More
LIFESENSORS ATTENDS BIO CONVENTION 2019 IN PHILADELPHIA The Bio International Convention will be in Philadelphia from June 3-6, 2019. More than 16,000 biotech and pharmaceutical leaders will attend and network to explore...
Read More
The Cold Spring Harbor Laboratory will be hosting a conference on the Ubiquitin Proteasome System (UPS) and associated Diseases April 23rd-27th. LifeSensors will be presenting on our most recent developments…
LifeSensors has spent years supporting the drug discovery efforts in Ubiquitin Proteasome System (UPS) research. We are excited to see this growing area of research gain more attention through conferences…
LifeSensors is a leader in Ubiquitin Proteasome System (UPS) drug discovery technologies and SUMO Platform for Difficult to Express Proteins. We are pleased to inform you that members of our...
Read More
LIFESENSORS IS PROUD TO SPONSOR THE 2018 FUSION UBIQUITIN CONFERENCE IN NASSAU, BAHAMAS It is with great pride that LifeSensors announces its sponsorship of the 2018 Fusion Conference The Ubiquitin…
WE HAVE DEVELOPED A NEW WEBSITE FOR CUSTOMERS TO FOLLOW OUR INNOVATIONS AND THE FUTURE OF MEDICINE BY EXPLORING THE UBIQUITIN AND SUMO PATHWAY CHECK OUT OUR NEW FEATURES LIFESENSORS…